Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to Crosslaps TM Elisa
Fledelius, C; Kolding, I; Qvist, Pet al.
1997 • In Scandinavian Journal of Clinical and Laboratory Investigation, 57, p. 73-83
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Hejgaard, J
Frokiaer, H
Christiansen, C
Language :
English
Title :
Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to Crosslaps TM Elisa
Publication date :
1997
Journal title :
Scandinavian Journal of Clinical and Laboratory Investigation
Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993; 8 Suppl 2): 549-55.
Kivirikko KI. Urinary excretion of hydroxyproline in health and disease. Int Rev Connect Res 1977; 5: 93-163.
Colwell A, Eastell R, Assiri AMA, Russel RGG. Effect of diet on deoxypyridinoline excretion. In: Christiansen C, Overgaard K, editors. Osteoporosis. Copenhagen: Osteopress ApS, 1990: 590-1.
Weiss PH, Klein L. The quantitative relationship of urinary peptide hydroxyproline excretion to collagen degradation. J Clin Invest 1969; 48: 1-10.
Reid KBM, Porler RR. Subunit and structure of subcomponent C1q of the first component of human complement. Biochem J 1976; 155: 10-23.
Pødenphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984; 142: 145-8.
Eyre DR, Koop TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984; 137: 380-8.
Eyre DR, Dickson IR, Van Ness K. Collagen crosslinking in human bone and articular cartilage. J Biochem 1988; 252: 495-500.
Eyre DR, Paz MA, Galop PM. Cross-linking in collagen and elastin. Ann Rev Biochem 1984; 53: 717-48.
Seyeden EM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA. Immunoassay for urinary pyridinoline: the new marker for bone resorption. J Bone Miner Res 1993; 8: 635-41.
Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994; 40: 2022-5.
Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption; quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992; 7: 1251-8.
Risteli J, Elonaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635-40.
Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864-8.
Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphanate and estrogen therapy on free and peptide-bound bone crosslinks excretion. J Bone Miner Res 1995; 79: 780-85.
Bjarnason N, Bjarnason K, Haarbo J, Rosenquist C, Christiansen C. Tibolone: prevention of bone loss in elderly postmenopausal women. J Clin Endocrinol Metab 1996; 81: 2419-22.
Soinila S, Mpitsos GJ, Soinila J. Immunohistochemistry of enkephalins: model studies on hapten-carrier conjugates and fixation methods. J Histochem Cytochem 1992; 40: 231-9.
Rosenquist C, Bonde M, Fledelius C, Qvist P. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 1994; 40: 1258-64.
Meyer K, Behringer DM, Veh RW. Antibodies against neuroactive amino acids and neuropeptides. I. A new two-step procedure for their conjugation to carrier proteins and the production of an anti-met-enkephalin antibody reactive with glutaraldehyde-fixed tissues. J Histochem Cytochem 1991; 39: 749-60.
Kearney JF, Radbruch, Liesegang B, Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybridoma cell lines. J Immunol 1979; 123: 1548-50.
Astaldi GGB, Janssen MC, Lansdorp P, Willems C, Zeijlemarker WP, Oosterhof F. Human endothelial supernatants (HECS): a growth factor for hybridomas. J Immunol 1980; 25: 1411-14.
Ishikawa E. Enzyme-labelling of antibodies. J Immunoassay 1983; 4: 209-327.
SAS Institute. SAS/STAT guide for personal computers. 6th ed., Cary, North Carolina: SAS Institute 1987
Kühn K. Clinical properties of collagen. In: Furthmayer H, editor, Immunochemistry of the extracellular matrix. Boca Raton, Florida: CRC Press 1982: 1-30.
Kadler K. Extracellular matrix 1: fibril-forming collagens. Protein profiles. 1994; 1: 517-638.
Fledelius C, Riis BJ, Overgaard K, Christiansen C. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int 1994; 54: 381-4.
Frijlink WB, Bijvoet OLM, Te Velde J, Heynen G. Treatment of Paget's disease with (3-amino-1-hydroxy-propylidene)-1-1-bisphosphonate (APB). Lancet 1979; i: 799-801.
